March 12th, 2020 only 350mg: The patient’s onco
Post# of 151395

The patient’s oncologist has now ordered this patient’s treatment to consist only of leronlimab and has discontinued treatment with carboplatin (a chemotherapy drug). Testimony provided to the Company from the patient stated: "So far my experience with leronlimab has been very positive. I didn’t expect it to be so easy and tolerable with virtually ZERO side effects. The results so far have been super impressive. I’m very grateful to be part of this clinical trial study and it really makes me feel hopeful that this otherwise fatal disease can be turned into a manageable disease in the near future."
This patient’s latest results of zero CTC, EMT, and CAML is unique and we now have another patient with three zeros identical to the first patient.
https://www.globenewswire.com/news-release/20...s-Mon.html
So there's at least 2 ladies with outstanding data before the basket enrollment.
We know basket trial -- Ladies of Leronlimab -- dosing was much higher than 325mg.
Wow!! @ the MOA clarity potential in May....

